menu search

attovia therapeutics launches with $60 million series a financing to unlock potential of novel biparatopic nanobody platform

Company Formed by Alamar Biosciences and Frazier Life Sciences Attobody™ Platform Generates Small Format Binders for Hard-to-drug Targets FREMONT, C...

June 20, 2023, 11:30 am


Search within

Pages Search Results: